Chromoendoscopy versus conventional endoscopy in Patients with polyposis syndrome

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2014-003546-27-DE

Enrollment

Registered

2016-02-02

Start date

2016-07-18

Completion date

Unknown

Last updated

2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Familial adenomatous polyposis MedDRA version: 19.0 Level: PT Classification code 10056981 Term: Adenomatous polyposis coli System Organ Class: 10010331 - Congenital, familial and genetic disorders

Interventions

Trade Name: Indigocarmin Amino Product Name: Indigocarmin Amino Pharmaceutical Form: Solution for injection INN or Proposed INN: Indigocarmin CAS Number: 860-22-0 Other descriptive name: INDIGO CARMIN

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 70 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 18

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Germany

Contacts

Public ContactDr. med. Christoph Coch

Studienzentrale SZB

Studienzentrale-SZB@ukb.uni-bonn.de004922828716040

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026